Tenon Medical acquires SI joint specific assets from SiVantage

Tenon Medical (TNON) as acquired sacroiliac joint specific assets from SiVantage. This strategic asset acquisition includes SiVantage’s SImmetry and SImmetry+ technologies expanding Tenon’s SI portfolio across multiple approaches to the variable sacro pelvic anatomy. These differentiated technologies enable physicians to customize treatment plans for their patients using novel authentic fusion products backed by clinical data. Transaction moves critical technologies, intellectual property, and commercial leadership of SiVantage to Tenon Medical. Core technology products are expected to contribute to revenue immediately. Enhanced product pipeline is significantly strengthened, accelerating innovation and market readiness. Supported by extensive clinical data, the integrated platform demonstrates a proven record of safety and performance. Tenon is now a multi-product, multi-approach sacro-pelvic organization. This strategic acquisition enhances Tenon’s unique ability to meet the evolving needs of physicians and their patients. SiVantage Co-Founders Wyatt Geist and Nate Grawey are joining Tenon’s management team as Chief Innovations Officer and Chief Commercial Officer, respectively – bringing decades of medical device experience and relationships, further strengthening the Company’s commercial leadership. The Company now offers a modern, integrated portfolio spanning SI joint fusion, spinal fusion, and deformity adjuncts-each engineered to help deliver reliable fusion outcomes. While others focus on fixation, Tenon prioritizes what truly matters: biologic fusion. Tenon’s implants and instruments are designed not just to stabilize, but to actively promote bone healing, minimize loosening, and restore lasting structural stability. Transaction structure includes a modest upfront cash component and an equity issuance representing a percentage of shares outstanding, with the majority of total consideration contingent upon achieving future performance milestones. Integration activities will commence immediately and will be completed in Q4 2025.